Patents by Inventor Ming X. Wei

Ming X. Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of tumors prostate with arsonoliposomes
    Publication number: 20120015023
    Abstract: The invention provides a method for treating a prostate proliferative disorder, such a prostate carcinoma or a begnin prostatic hyperplasia, in a patient, which method comprises administering arsonoliposomes comprising arsonolipids, wherein the arsonolipids are 2,3-diacyloxypropylarsonic acids, to a patient in need thereof.
    Type: Application
    Filed: April 15, 2011
    Publication date: January 19, 2012
    Inventors: Sophia G. Antimisiaris, Panayiotis V. Ioannou, Ming X. Wei
  • Method of selectively destroying neoplastic cells
    Patent number: 5688773
    Abstract: A method for selectively killing nervous system and peripheral neoplastic cells is provided. Viral vectors are used to selectively express a cytochrome P450 gene in neoplastic cells, whose gene product targets the cells for selective killing, by rendering the cells sensitive to a chemotherapeutic agent.
    Type: Grant
    Filed: October 28, 1994
    Date of Patent: November 18, 1997
    Assignees: The General Hospital Corporation, Boston University, Dana-Farber Cancer Institute
    Inventors: E. Antonio Chiocca, David J. Waxman, Ming X. Wei, Xandra O. Breakefield, Ling Chen